SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

FHS
July 4, 2023
1:26 pm

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs

An organization scouring thousands of existing drugs to see if any can cure hard-to-treat diseases has a powerful new ally: Janet Woodcock, who for decades

October 7, 2024

Fibrin fuels thromboinflammation and brain damage in COVID-19

Researchers reveal fibrin’s critical role in COVID-19 by driving thromboinflammation and neuropathology, and highlight a potential antibody therapy to mitigate these effects.

August 30, 2024

The race to build better CRISPR delivery vehicles is heating up

If the first CRISPR decade was marked by a mad dash to evolve, engineer, and mine the bacterial universe for more and better genome-editing enzymes,

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.